GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Amoy Diagnostics Co Ltd (SZSE:300685) » Definitions » Cyclically Adjusted PS Ratio

Amoy Diagnostics Co (SZSE:300685) Cyclically Adjusted PS Ratio : 10.23 (As of Jun. 05, 2025)


View and export this data going back to 2017. Start your Free Trial

What is Amoy Diagnostics Co Cyclically Adjusted PS Ratio?

As of today (2025-06-05), Amoy Diagnostics Co's current share price is ¥20.87. Amoy Diagnostics Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was ¥2.04. Amoy Diagnostics Co's Cyclically Adjusted PS Ratio for today is 10.23.

The historical rank and industry rank for Amoy Diagnostics Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

SZSE:300685' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 9.83   Med: 10.21   Max: 11.22
Current: 10.24

During the past years, Amoy Diagnostics Co's highest Cyclically Adjusted PS Ratio was 11.22. The lowest was 9.83. And the median was 10.21.

SZSE:300685's Cyclically Adjusted PS Ratio is ranked worse than
92.42% of 132 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.085 vs SZSE:300685: 10.24

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Amoy Diagnostics Co's adjusted revenue per share data for the three months ended in Mar. 2025 was ¥0.692. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ¥2.04 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Amoy Diagnostics Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Amoy Diagnostics Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amoy Diagnostics Co Cyclically Adjusted PS Ratio Chart

Amoy Diagnostics Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Amoy Diagnostics Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 10.99

Competitive Comparison of Amoy Diagnostics Co's Cyclically Adjusted PS Ratio

For the Diagnostics & Research subindustry, Amoy Diagnostics Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Amoy Diagnostics Co's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Amoy Diagnostics Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Amoy Diagnostics Co's Cyclically Adjusted PS Ratio falls into.


;
;

Amoy Diagnostics Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Amoy Diagnostics Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=20.87/2.04
=10.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amoy Diagnostics Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Amoy Diagnostics Co's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.692/115.1156*115.1156
=0.692

Current CPI (Mar. 2025) = 115.1156.

Amoy Diagnostics Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201212 0.000 95.237 0.000
201312 0.000 97.624 0.000
201412 0.000 99.000 0.000
201506 0.000 99.500 0.000
201512 0.000 100.600 0.000
201609 0.230 102.400 0.259
201612 0.249 102.600 0.279
201703 0.209 103.200 0.233
201706 0.532 103.100 0.594
201709 0.242 104.100 0.268
201712 0.263 104.500 0.290
201803 0.224 105.300 0.245
201806 0.294 104.900 0.323
201809 0.278 106.600 0.300
201812 0.330 106.500 0.357
201903 0.312 107.700 0.333
201906 0.563 107.700 0.602
201909 0.557 109.800 0.584
201912 0.653 111.200 0.676
202003 0.350 112.300 0.359
202006 0.350 110.400 0.365
202009 0.517 111.700 0.533
202012 0.599 111.500 0.618
202103 0.445 112.662 0.455
202106 0.557 111.769 0.574
202109 0.604 112.215 0.620
202112 0.690 113.108 0.702
202203 0.500 114.335 0.503
202206 0.467 114.558 0.469
202209 0.531 115.339 0.530
202212 0.650 115.116 0.650
202303 0.477 115.116 0.477
202306 0.688 114.558 0.691
202309 0.634 115.339 0.633
202312 0.839 114.781 0.841
202403 0.581 115.227 0.580
202406 0.778 114.781 0.780
202409 0.768 115.785 0.764
202412 0.658 114.893 0.659
202503 0.692 115.116 0.692

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Amoy Diagnostics Co  (SZSE:300685) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Amoy Diagnostics Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Amoy Diagnostics Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Amoy Diagnostics Co Business Description

Traded in Other Exchanges
N/A
Address
39 Dingshan Road, Haicang District, Xiamen, CHN, 361027
Amoy Diagnostics Co Ltd is the pharmaceutical company based in China. The company primarily focuses on molecular diagnostics for oncology precision medicine. It provides diagnostic products and services for medicine development and clinical oncology practice. The company's products include gene mutation, nucleic acid extraction, and molecular diagnostic kits comprising EGFR, RAS, ALK, BRAF, PIK3CA, and ROS1 testing kits.
Executives
Ruan Li Directors, executives
Zheng Hui Bin Directors, executives
Chen Ying Directors, executives
Luo Jie Min Executives
Zhu Guan Shan Directors, executives
Yang Shou Qian Securities Affairs Representative
Zhou Wen Gang Executives
Zhou Xue Lin Independent director
Hu Xu Bo Director

Amoy Diagnostics Co Headlines

No Headlines